Search results
Could This Drug News Lift AbbVie's Stock?
Motley Fool· 1 year agoConsider AbbVie's (NYSE: ABBV) crown jewel drug, Humira, which hauled in $21.2 billion in revenue in 2022. The good news is that AbbVie knew this day...
Better Growth Stock: Abbott vs. AbbVie
Motley Fool via Yahoo Finance· 4 months agoAbbott Laboratories (NYSE: ABT) and AbbVie (NYSE: ABBV) share a common past. About a decade ago, Abbott spun out its pharmaceuticals business into a...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 1 month agoAbbVie is "firing on all cylinders," an analyst said Friday after the pharma giant beat Wall...
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market....
![AbbVie Insiders Sell US$8.4m Of Stock, Possibly Signalling Caution \](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7 "AbbVie Insiders Sell US$8.4m Of Stock, Possibly Signalling Caution \")
AbbVie Insiders Sell US$8.4m Of Stock, Possibly Signalling Caution \
Simply Wall St. via Yahoo Finance· 12 months agoOver the past year, many AbbVie Inc. (NYSE:ABBV) insiders sold a significant stake in the company...
Here's What This Drug News Could Mean for AbbVie's Shareholders
Motley Fool· 2 years agoOn May 11, AbbVie (NYSE: ABBV) announced positive top-line results in its phase 3 clinical trial of...
Why Abbvie Stock Popped Today
Motley Fool· 6 months agoThe big asset buy in the healthcare industry provided a healthy pop to the two companies involved on Thursday. The stock price of the buyer, sector...
AbbVie Results Fall But The Drop Isn't As Severe As Expected; Shares Climb
Investor's Business Daily· 10 months agoDrug maker AbbVie on Thursday reported second-quarter profit and sales that fell from a year earlier...
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 months agoImage source: The Motley Fool. AbbVie (NYSE: ABBV) Q4 2023 Earnings Call Feb 02, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Cerevel options trading surge before AbbVie deal news raises eyebrows
Reuters via Yahoo News· 6 months agoNEW YORK (Reuters) -Trading in the options of Cerevel Therapeutics Holdings Inc experienced an...
![AbbVie Insiders Sell US$8.4m Of Stock, Possibly Signalling Caution \](https://s.yimg.com/fz/api/res/1.2/t9fwGymLi8166mGveKJYuQ--~C/YXBwaWQ9c3JjaGRkO2ZpPWZpbGw7aD05MjtweG9mZj0wO3B5b2ZmPTA7cT04MDtzbT0xO3c9MTY0/https://media.zenfs.com/en/simply_wall_st__316/b1235bf6d18ebc2cd7323427468d0693 "AbbVie Insiders Sell US$8.4m Of Stock, Possibly Signalling Caution \")
